Pharmafile Logo

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want – again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 1 Regents Drive Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
01661 831 811

 Latest Content from PMHub 

Pegasus Moves to Brighton

Press Releases | April 29, 2014 | Inizio

Top UK Healthcare Communications Consultancy Moves to Brighton

UX: Designing Human Experiences

Applying science to the creative process to improve lives

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

07 Good Pharma

Better for patients, better for business

05 Social Media: A Health Hazard?

The case to embrace going social

Creating a Lifeline to the New Digital User

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

White Papers and Resources | December 19, 2013 | Inizio

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

White Papers and Resources | December 19, 2013 | Inizio

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.